Christopher Martell - 08 Dec 2022 Form 4/A - Amendment Insider Report for Candel Therapeutics, Inc. (CADL)

Role
Director
Signature
/s/ Jason A. Amello, as Attorney-in-Fact for Christopher Martell
Issuer symbol
CADL
Transactions as of
08 Dec 2022
Net transactions value
+$51,108
Form type
4/A - Amendment
Filing time
17 Feb 2023, 17:40:24 UTC
Date Of Original Report
12 Dec 2022
Previous filing
17 Oct 2022
Next filing
29 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CADL Common Stock Purchase $5,124 +3,050 +2.4% $1.68 128,050 08 Dec 2022 By GTAM1 2012 LLC F1, F3
transaction CADL Common Stock Purchase $45,984 +23,950 +19% $1.92 152,000 09 Dec 2022 By GTAM1 2012 LLC F2, F3
holding CADL Common Stock 283,514 08 Dec 2022 By GTAM1 2012 ADV LLC F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.55 to $1.80. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 The price in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.88 to $1.98. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 Shares held by GTAM1 2012 LLC, which is wholly owned by a trust for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any.
F4 Shares held by GTAM1 2012 ADV LLC, for which the Reporting Person serves as manager. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any.

Remarks:

This amendment to the Form 4 originally filed by the Reporting Person on December 12, 2022 is being filed (i) to include indirect holdings that were inadvertently omitted from the original filing (as further described in footnotes 3 and 4 above) and (ii) to correct the number of shares held indirectly by the Reporting Person following the reported transactions.